Adma Biologics (ADMA) FCF Margin Growth (1y) (2012 - 2025)
Adma Biologics (ADMA) FCF Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,554.00 |
| Sep 30, 2025 | -2,080.00 |
| Jun 30, 2025 | -2,531.00 |
| Mar 31, 2025 | -1,566.00 |
| Dec 31, 2024 | 1,818.00 |
| Sep 30, 2024 | 980.00 |
| Jun 30, 2024 | 5,218.00 |
| Mar 31, 2024 | 2,371.00 |
| Dec 31, 2023 | 4,445.00 |
| Sep 30, 2023 | 5,077.00 |
| Jun 30, 2023 | 1,083.00 |
| Mar 31, 2023 | 6,986.00 |
| Dec 31, 2022 | 4,527.00 |
| Sep 30, 2022 | 3,778.00 |
| Jun 30, 2022 | 18,368.00 |
| Mar 31, 2022 | 12,392.00 |
| Dec 31, 2021 | 18,912.00 |
| Sep 30, 2021 | 18,184.00 |
| Jun 30, 2021 | 12,080.00 |
| Mar 31, 2021 | 3,891.00 |